Semaglutide, the active ingredient in Ozempic, Wegovy and Rybelsus, was associated with a lower risk of worsening mental health, the study published in Lancet Psychiatry found
Semaglutide, for example, has FDA-approved cardiovascular benefits for certain patients, while tirzepatide is also approved to treat obstructive sleep apnea in adults with obesity
Healthy fats activate specific receptors (FFAR1 and FFAR4) that prompt GLP-1 release
These systems utilize nanoparticles or nanocarriers to encapsulate drugs and protect them from degradation, ensuring their efficacy and prolonged shelf life
The individual strain-level evidence is encouraging
Lets work together towards your well-being